Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
607,324
-
Shares change
-
-36,515
-
Total reported value, excl. options
-
$67,362,554
-
Value change
-
-$4,554,735
-
Put/Call ratio
-
89%
-
Number of buys
-
25
-
Number of sells
-
34
-
Price
-
$110.71
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2018
As of 31 Dec 2018 VANECK ETF TRUST - BIOTECH ETF (BBH) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 607,324 shares of stock of the company.
Largest 10 holders included UBS Group AG, MORGAN STANLEY, ROYAL BANK OF CANADA, MURPHY CAPITAL MANAGEMENT INC, Virtu Financial LLC, Strategic Financial Services, Inc,, CITADEL ADVISORS LLC, BANK OF AMERICA CORP /DE/, MOGY JOEL R INVESTMENT COUNSEL INC, and RAYMOND JAMES & ASSOCIATES.
This table shows 82 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.